Armata Pharmaceuticals (ARMP) Tax Provisions (2017)
Quarterly results put Tax Provisions at -$1.3 million for Q2 2017, changed N/A from a year ago — trailing twelve months through Dec 2017 was -$1.4 million (changed N/A YoY), and the annual figure for FY2018 was -$328000.0, up 74.81%.
Armata Pharmaceuticals has reported Tax Provisions over the past 2 years, most recently at -$1.3 million for Q2 2017.
- Tax Provisions reached -$1.3 million in Q2 2017 per ARMP's latest filing, down from -$73000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at -$73000.0 in Q4 2015 and bottomed at -$1.3 million in Q2 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -11.20 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 221.50 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 104.00 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 216,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 15.66 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | -1.30 Mn |